John Oyler - Chief Executive Officer, Director at BeiGene, Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ONC on Nasdaq, BEIGF on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

John Oyler - trading volume in the past year for BeiGene, Ltd.

Holdings reported by John Oyler for BeiGene, Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 6.44M $2.19B $340.70 Nov 12, 2025 Direct
Ordinary Shares 102K $34.8M $340.70 Nov 11, 2025 Indirect
American Depositary Shares 0 $0 $327.78 Sep 16, 2025 Direct
Share Option (Right to Buy) 348K Jun 10, 2025 Direct Ordinary Shares

Transactions reported by John Oyler for BeiGene, Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.